Chiracon

Luckenwalde, Brandenburg, Germany
Small Molecule API Intermediates Clinical Trial Manufacturing
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Chiracon

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Luckenwalde, Brandenburg, Germany
Website
Modalities
Small Molecule API, Intermediates, Clinical Trial Manufacturing
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Chiracon

Chiracon is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Intermediates, Clinical Trial Manufacturing. 1 manufacturing site registered with the U.S. FDA. Website: https://chiracon.de/services/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Chiracon FDA Inspection History

2025-10
2023-09
NAI VAI OAI
Date Site Type Observations Classification
2025-10-17
Chiracon GmbH
Luckenwalde Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-09-29
Chiracon GmbH
Luckenwalde Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Chiracon

How many FDA inspections does Chiracon have on record?
CDMO Signal tracks 2 FDA inspections for Chiracon, sourced from the FDA inspection database. See the full inspection history above.
Has Chiracon received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Chiracon.
Does Chiracon have a CDMO Signal Score?
Not yet. Chiracon is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Chiracon for a manufacturing program?
Use the free AI matchmaker to compare Chiracon against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

DAPIN
Halle (Westfalen), Germany
Small Molecule API, Intermediates, Custom Synthesis, Clinical Trial Manufacturing
Agno Pharma
Lianyungang, Jiangsu, China
Small Molecule API, Intermediates, Sterile Injectables, Clinical Trial Manufacturing
Katayama Seiyakusyo
Hirakata, Osaka, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Oral Solid Dose
Symeres
Nijmegen, Netherlands
Small Molecule API, Clinical Trial Manufacturing, Intermediates, Spray Drying
UBE Corporation (pharmaceutical contract manufacturing)
Ube, Yamaguchi, Japan
Small Molecule API, Intermediates, High-Potency APIs, Clinical Trial Manufacturing

Compare Chiracon with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Chiracon
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.